Search

Author/Creator Patel, D.

3. 2241 Outcome of peptide receptor radionuclide therapy with 177Luoctreotate in advanced neuroendocrine tumours (NET): South Australian sub study of the SIGNETURe Registry. (September 2015)

Authors:
Patel, D.; Lawrie, J.; Cehic, G.; Kitchener, M.; Unger, S.; Singhal, N.; Karapetis, C.; Michael, M.; Kotasek, D.; Chua, Y.J.; Price, T.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S413
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 3087 Characteristics and treatment patterns of ALK+ NSCLC patients who receive second-generation ALK inhibitors: A chart review study. (September 2015)

Authors:
Cadranel, J.; Park, K.; Pless, M.; Bendaly, E.; Patel, D.; Sasane, M.; Swallow, E.; Galebach, P.; Stein, K.; Marinsek, N.; Zhang, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S627
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 3108 Treatment Patterns and Survival among ALK+ Non-Small Cell Lung Cancer (NSCLC) Patients: A Chart Review Study. (September 2015)

Authors:
Park, K.; Cadranel, J.; Arrieta, O.; Pless, M.; Bendaly, E.; Patel, D.; Sasane, M.; Nosal, A.; Guerin, A.; Kageleiry, A.; Stein, K.; Marinsek, N.; Zhang, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S638
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 3114 Testing and treatment practice of oncologists managing ALK+ NSCLC: international physician survey across four regions. (September 2015)

Authors:
Arrieta, O.; Cadranel, J.; Park, K.; Pless, M.; Bendaly, E.; Patel, D.; Sasane, M.; Nosal, A.; Macalalad, A.R.; Kercheval, J.; Stein, K.; Weiss, J.; Zhang, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S641
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. A Novel, Blocking, Fc‐Silent Anti‐CD40 Monoclonal Antibody Prolongs Nonhuman Primate Renal Allograft Survival in the Absence of B Cell Depletion. Issue 11 (2nd July 2015)

Authors:
Cordoba, F.; Wieczorek, G.; Audet, M.; Roth, L.; Schneider, M. A.; Kunkler, A.; Stuber, N.; Erard, M.; Ceci, M.; Baumgartner, R.; Apolloni, R.; Cattini, A.; Robert, G.; Ristig, D.; Munz, J.; Haeberli, L.; Grau, R.; Sickert, D.; Heusser, C.; Espie, P.
Journal:
American journal of transplantation
Issue:
Volume 15:Issue 11(2015:Nov.)
Page Start:
2825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗